Drug Price Controls
The Issue
There is concern among the general public about the cost of pharmaceuticals. Consumer advocates have issued a number of studies raising alarms about the rising prices that have resulted in proposals to put in place artificial caps.
Our Position
We are concerned that there are those who struggle to pay for their medications. Price controls, however, will do little but hamper the future development of new and better pharmaceuticals. The free market attracts investors willing to take the risks needed for successful innovation. We believe better alternatives are targeted government and private programs that help low income individuals afford the medications they need.
About MassBio
MassBio, founded in 1985, is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.
Latest Updates
- March 8, 2010 Biocell Center Corporation Partners with New England's Largest Community-Based Hospital Network to Offer a Unique Service in Amniotic Fluid Stem Cell Preservation
- March 8, 2010 LES Spring Meeting: Linking Entrepreneurship and Technology Commercialization
- March 5, 2010 MassBioEd Course: Four Day Leadership Training Program for Scientists
- March 2, 2010 JOULE NAMED AMONG 50 MOST INNOVATIVE COMPANIES IN THE WORLD
- March 2, 2010 Pharmarama Launches Cold-Chain and Ambient Storage and Distribution Hub for Pharmaceutical Clients